Physician

Emily Triana Marx, M.D.

According to 2025 Medicare claims, Emily Marx, M.D. (NPI: 1144491002) practices rheumatology in the San Antonio-New Braunfels, TX market, with the plurality of this provider's patient population coming from Bexar, TX. This provider's primary affiliated billing organization is RHEUMATOLOGY ASSOCIATES OF SOUTH TEXAS, PLLC (NPI: 1952351538; TIN: 161751617) and primary practice location at 78258-3372. Marx is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Marx's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 479 traditional Medicare patients, billed 178,728 HCPCS/CPT codes, and received $2,830,933 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,041 prescription claims across 312 beneficiaries totaling $1,341,011 in drug costs, led by Otezla (Apremilast). Open Payments data shows 83 records totaling $1,545. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,154,160 to $2,830,933. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $1,412,688 and ending at $1,341,011. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	258	84,968	$1,154,160
2016	227	66,199	$720,472
2017	254	81,445	$1,011,164
2018	262	58,148	$998,662
2019	280	71,463	$1,386,494
2020	317	78,240	$1,914,777
2021	359	121,640	$2,124,890
2022	438	124,768	$2,128,593
2023	485	129,157	$1,907,353
2024	479	178,728	$2,830,933

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	218	2,254	$1,412,688
2016	184	1,955	$1,297,986
2017	198	1,380	$662,601
2018	202	1,303	$610,982
2019	223	1,584	$1,184,761
2020	270	2,006	$1,212,316
2021	285	2,151	$1,398,181
2022	303	2,232	$1,510,463
2023	296	2,021	$1,685,766
2024	312	2,041	$1,341,011

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	365	1,053	$88
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	351	811	$12
80053	Blood test, comprehensive group of blood chemicals	354	1,101	$10
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	344	1,036	$8
86140	Measurement c-reactive protein for detection of infection or inflammation	330	970	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Otezla	Apremilast	39	1,394	$228,831
Enbrel Sureclick	Etanercept	19	532	$144,737
Humira(Cf) Pen	Adalimumab	18	504	$139,461
Rinvoq	Upadacitinib	17	510	$113,448
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	446	23,589	$14,700

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	83	$1,545	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Emily Triana Marx, M.D.?

Tedicare shows public-source Medicare data for Emily Triana Marx, M.D. (NPI 1144491002), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Emily Triana Marx, M.D. have ACO affiliation data?

Emily Triana Marx, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Emily Triana Marx, M.D.?

Emily Triana Marx, M.D. is linked to RHEUMATOLOGY ASSOCIATES OF SOUTH TEXAS, PLLC (billing NPI 1952351538) in the available physician profile data.

Does Emily Triana Marx, M.D. have Open Payments data?

Emily Triana Marx, M.D. has 83 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.